Back | Next |
home / stock / hook / hook message board
Subject | By | Source | When |
---|---|---|---|
... here we go ... | wile.e.coyote | investorshub | 02/16/2022 7:11:38 PM |
$HOOK=$$$$$$: | Just-Keep-Trying | investorshub | 02/16/2022 6:14:46 PM |
$HOOK: Good summary of what is transpiring behind | Just-Keep-Trying | investorshub | 02/16/2022 5:47:47 PM |
Yep looks like multi day runner | TimeFades | investorshub | 02/16/2022 5:22:42 PM |
$HOOK: 56% UP this day, & climbing. (You | Just-Keep-Trying | investorshub | 02/16/2022 3:53:19 PM |
$HOOK should at least Close today up circa | Just-Keep-Trying | investorshub | 02/16/2022 3:50:42 PM |
Nice churn lets see . Not much else | TimeFades | investorshub | 02/16/2022 3:11:26 PM |
$HOOK=$$$$: If this kind of news doesn't send | Just-Keep-Trying | investorshub | 02/16/2022 3:07:55 PM |
somebody knows something... ;-) | alchemytrader | investorshub | 02/16/2022 3:01:52 PM |
Lets f goooo | MADDSTACKER | investorshub | 02/16/2022 2:15:19 PM |
Shorts caught on the hook, and getting squeezed | trendzone | investorshub | 02/15/2022 9:59:32 PM |
Grabbed 1k here figured why not | MADDSTACKER | investorshub | 02/04/2022 8:47:03 PM |
$HOOK- Fascinating SEC filing yesterday. Management is waiving | stockguard | investorshub | 02/03/2022 11:42:11 PM |
Garnering much interest, now. | KeepOn | investorshub | 02/03/2022 1:01:58 AM |
Date of Earliest Transaction (Month/Day/Year) | stockguard | investorshub | 01/13/2022 7:44:55 PM |
At 52 week low this is very oversold | stockguard | investorshub | 01/11/2022 9:06:13 PM |
JMP Securities Hematology and Oncology Summit | stockguard | investorshub | 12/08/2021 7:10:58 PM |
Analysts Set Hookipa Pharma Inc (NASDAQ:$HOOK) Target Price | stockguard | investorshub | 12/08/2021 6:20:42 PM |
Biotech Is in the Dumps Because of Private | stockguard | investorshub | 12/07/2021 6:53:06 PM |
znewcar1: HOOK +24% v775K c9.96 f25M H 10.39 late morning vol of 25K/min pushed it to 9.5 then VWAP | znewcar1 | investorshangout | 12/19/2019 12:44:44 AM |
News, Short Squeeze, Breakout and More Instantly...
Company will present promising preliminary progression-free survival and overall survival data for patients with combined positive score (CPS) ??...
Company will present promising preliminary progression-free survival and overall survival data for patients with combined positive score (CPS) ≥20 Conference call on Tuesday, June 4, at 4:15 p.m. ET NEW YORK and VIENNA, May 30, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc....
HOOKIPA to present an oral abstract at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting on June 4 Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile and promising clinical activity In a subset of patients with PD-L1 combined posit...